AquaNab raises funding to fight salmon’s $4bn sea lice problem with alpaca nanoantibodies
Hamburg biotech is taking an unusual shot at salmon farming’s most expensive pest, and it starts with an alpaca. AquaNab is developing tiny antibodies, derived from the animals and delivered through fish feed, to treat and prevent sea lice. The parasite it is chasing is a genuine scourge. Sea lice cost the aquaculture industry billions […] This story continues at The Next Web
This is a summary aggregated from NextWeb. Read the complete article on the original site:
Read full article at NextWeb